Hormonal contraception and HIV disease progression

Clinical Infectious Diseases

Volumn 47, Issue 7, 2008, Pages 945-951

  Stringer, Elizabeth ^a,c   Antonsen, Erik ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BIRTH CONTROL; DISEASE COURSE; DRUG EFFECT; DRUG MEGADOSE; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; LOW DRUG DOSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CONTRACEPTIVES, ORAL, HORMONAL; DISEASE PROGRESSION; ESTROGENS; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PROGESTERONE;

EID: 52449128773     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/591697     Document Type: Review

References (54)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization. Report on the global HIV/AIDS epidemic 2007. Geneva: UNAIDS, 2007.
2. Shah IH, Say L. Maternal mortality and maternity care from 1990 to 2005: uneven but important gains. Reproductive Health Matters 2007; 15:17-27.
3. Reynolds HW, Janowitz B, Homan R, Johnson L. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006; 33:350-6.
4. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105:827-35.
5. van Benthem BH, Vernazza P, Coutinho RA, Prins M. Impact of pregnancy and menopause on CD4 cell counts. J Acquir Immune Defic Syndr 2005; 38(Suppl 1):S22.
6. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999; 21:51-8.
7. Baeten JM, Lavreys L, Sagar M, et al. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr 2005; 38(Suppl 1):S18-21.
8. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
9. Lavreys L, Baeten JM, Martin HL Jr, et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 2004; 18:695-7.
10. Jacobson DL, Peralta L, Farmer M, Graham NM, Gavdos C, Zenilman J. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 2000; 27:313-9.
11. Wang CC, McClelland RS, Overbaugh J, et al. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 2004; 18:205-9.
12. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-7.
13. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993; 269:2860-4.
14. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-9.
15. Trunova N, Tsai L, Tung S, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006; 352:169-77.
16. Brumme ZL, Goodrich J, Mayer HB, et al. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. J Infect Dis 2005; 192:466-74.
17. Abel K, Rourke T, Lu D, Bost K, McChesney MB, Miller CJ. Abrogation of attenuated lentivirus-induced protection in Rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis 2004; 190:1697-705.
18. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
19. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type (HIV-1) illness predict mortality among high-risk HIV infected African women. Clin Infect Dis 2006; 42:1333-9.
20. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol 2007; 197:144.e1-8.
21. Cejtin HE, Jacobson L, Springer G, et al. Effect of hormonal contraceptive use on plasma HIV-1 RNA levels among HIV-infected women. AIDS 2003; 17:1702-4.
22. Richardson BA, Otieno PA, Mbori-Ngacha, Overbaugh J, Farquhar C, John-Stewart GC. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS 2007; 21:749-53.
23. Sagar M, Lavreys L, Baeten JM, et al. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J Virol 2003; 77:12921-6.
24. Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther 2007; 4:11.
25. Nilsson J, Boasso A, Velilla PA, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108:3808-17.
26. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 2007; 42:432-7.
27. + T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2:E20.
28. Enomoto LM, Kloberdanz KJ, Mack DG, Elizabeth D, Weinberg A. Ex vivo effect of estrogen and progesterone compared with dexamethasone on cell-mediated immunity of HIV-infected and uninfected subjects. J Acquir Immune Defic Syndr 2007; 45:137-43.
29. Maret A, Coudert JD, Garidou L, et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo: essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003; 33:512-21.
30. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997; 158:446-51.
31. Hughes GC, Thomas S, Li C, Kaja MK, Clark EA. Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells. J Immunol 2008; 180:2029-33.
32. Chinen J, Shearer WT. Molecular virology and immunology of HIV infection. J Allergy Clin Immunol 2002; 110:189-98.
33. Connolly NC, Riddler SA, Rinaldo CR. Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches. AIDS Reviews 2005; 7:168-80.
34. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18:349-56.
35. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24:677-88.
36. Cervasi B, Brenchley J, Piaiardini M, et al. Preferential loss of Th17 CD4 T cells in the gastrointestinal tract of HIV-infected individuals but not SIV-infected sooty mangabeys [abstract 115]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston, MA). 2008.
37. Checchinato V, Trindad C, Heraud JM, et al. Preferential loss of Th17 T cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques [abstract 116]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston, MA). 2008.
38. Dandekar S, Rafatellu M, Macal M, et al. Disruption of intestinal epithelial integrity and increased microbial translocation and systemic dissemination in HIV and SIV infections are linked to impaired IL-17-expressing mucosal T cell responses [abstract 374]. In: Programand abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston, MA). 2008.
39. Favre D, Lederer S, Kanwar B, et al. Primary SIV infection causes rapid loss of the balance between TH17 and T regulatory cell populations in pathogenic infection of non-human primates [abstract 117LB]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston, MA). 2008.
40. + T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109:3351-9.
41. Appay V, Almeida JR, Sauce D, Autran B, Papagno L. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 2007; 42:432-7.
42. + T cells. Blood 2003; 101:2711-20.
43. Danel L, Vincent C, Rousset F, et al. Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem 1988; 30:363-7.
44. Pasanen S, Ylikomi T, Palojoki E, Syvala H, Pelto-Huikko M, Tuohimaa P. Progesterone receptor in chicken bursa of Fabricius and thymus: evidence for expression in B-lymphocytes. Mol Cell Endocrinol 1998; 141:119-28.
45. Laskarin G, Strbo N, Sotosek V, et al. Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 1999; 42:312-20.
46. Laskarin G, Tokmadzic VS, Strbo N, et al. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol 2002; 48:201-9.
47. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283:1277-8.
48. + T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998; 161:3365-74.
49. Katagiri D, Hayashi H, Victoriano AF, Okamoto T, Onozaki K. Estrogen stimulates transcription of human immunodeficiency virus type 1 (HIV-1). Int Immunopharmacol 2006; 6:170-81.
50. Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-κ B. J Neuroimmunol 2002; 124:106-14.
51. + T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002; 54:117-31.
52. + T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis 2000; 181:927-32.
53. + T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-70.
54. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.